ALFA Filings
Every announcement, straight from the exchange
Every Alivus Life Sciences results update announcement on NSE and BSE, newest first, each with its own page.
Time
2 announcements with these filters
Alivus Life Sciences reported Q1 FY27 financial highlights with revenue growing 6.4% YoY to Rs. 6,404 million and PAT rising 31.8% YoY.
Alivus Life Sciences reported FY26 revenue growth of 6.9% YoY and EBITDA margins of 33.6%. The company also announced a new R&D centre in Taloja.